Artificial Intelligence in Medtech
The emergence of artificial intelligence (AI) and machine learning (ML) can be seen across multiple industries, transforming everything from healthcare to transportation. Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the medtech industry are playing a major role in improving patients’ lives through innovative care, reduced healthcare costs, and improved patient outcomes.
Related Reading
News / Health Access / Regulatory Affairs
AdvaMed Spotlights Small Company Innovation Award Winners at The MedTech Conference 2026
October 22, 2026
BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, held October 18-21 in Boston. The conference recognized companies developing technologies to address a diverse array of patient needs through awards offered in several competitions and programs.
News / Health Access / Regulatory Affairs
AdvaMed Convenes 13th Annual Symposium on Pediatric Device Innovation
October 22, 2026
BOSTON—AdvaMed, the Medtech Association, convened the 13th Annual Symposium on Pediatric Device Innovation on October 18 at The MedTech Conference 2026 in Boston. In collaboration with the five U.S. Food and Drug Administration-funded Pediatric Device Consortia and with support from the Mussallem CHD Alliance, the symposium brought together innovators, clinicians, regulators, investors, and patient advocates to address the evidence and access barriers that keep promising technologies from reaching children.
News / Medical Imaging / Regulatory Affairs / Standards
AdvaMed Names GE HealthCare’s John Jaeckle the 2026 Imaging Röntgen Award Recipient
October 16, 2026
WASHINGTON — AdvaMed, the Medtech Association, today announced that John Jaeckle, Chief Regulatory Affairs Strategist, at GE HealthCare, is the recipient of the 2026 AdvaMed Imaging Röntgen Award. The award recognizes Jaeckle’s more than 25 years of leadership in medical imaging regulation and standards development, including his work to advance computed tomography technology, performance and regulatory alignment in the United States and worldwide.
News / Health Access / Regulatory Affairs
AdvaMed Recommends Steps to Strengthen RAPID Pathway for Breakthrough Medical Technologies
October 8, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today recommended refinements the Centers for Medicare & Medicaid Services (CMS) could make to help its proposed Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway deliver more timely access to breakthrough medtech for Medicare beneficiaries.
News / Artificial Intelligence (AI) / Health Access
Paradromics Demonstrates Four Years of Stable Neural Recording in Major Brain-Computer Interface Durability Milestone
October 8, 2026
AUSTIN, Texas – October 8, 2026 – Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces (BCIs) to restore and enhance human capabilities, today announced that its brain-computer interface has demonstrated more than four years of stable neural recording and decoding performance.
Resource / Artificial Intelligence (AI)
MedTech 2026 Trends: Engineering Outcomes, Intelligence and Trust
October 2, 2026
Explore the engineering, technology and compliance shifts shaping medtech in 2026, from patient-centric innovation to evolving global frameworks.
Resource / Artificial Intelligence (AI)
Physical AI in MedTech: Why the Hard Questions Matter more than the Hype
October 1, 2026
Explore how Physical AI is transforming medtech and the key challenges around trust, regulation, integration and collaboration that will shape its future.
Event / Regulatory Affairs
AdvaMed Medical Device Submission Workshop Series
February 9, 2027 – February 28, 2027
Join industry leaders for the in-depth Medical Device Submissions Workshop series to receive real-world case studies, timely submissions tips, and best practices.
